Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sp-8-Cl-cAMPS, an analogue of cAMP and a derivative of Sp-8-Cl-cAMP, inhibits the growth of human leukemia cells (HL-60) and colon cancer cells (LS-174T) with an IC50 ranging from 8-100 μM. Additionally, it activates protein kinases cAKI and cAKII, with Ka values of 0.25 μM and 3.2 μM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Sp-8-Cl-cAMPS, an analogue of cAMP and a derivative of Sp-8-Cl-cAMP, inhibits the growth of human leukemia cells (HL-60) and colon cancer cells (LS-174T) with an IC50 ranging from 8-100 μM. Additionally, it activates protein kinases cAKI and cAKII, with Ka values of 0.25 μM and 3.2 μM, respectively. |
Molecular Weight | 320.39 |
Formula | C20H20N2O2 |
Cas No. | 3027413-48-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.